Luca Testa

Showing 1-14 of 14 articles

First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial

Chieffo A, Khawaja S, Latib A, Vesga B, Moncada M, Delgado J, Fonseca J, Testa L, Esposito G, Ferrone M, Cortese B, Maehara A, Granada J, Colombo A

June 12, 2020 | 10.4244/EIJ-D-19-00600

Transcatheter aortic valve implantation with the Portico and Evolut R bioprostheses in patients with elliptic aortic annulus

Gorla R, De Marco F, Morganti S, Finotello A, Brambilla N, Testa L, Agnifili M, Tusa M, Auricchio F, Bedogni F

April 3, 2020 | 10.4244/EIJ-D-19-00115

Intravascular ultrasound in the evaluation and treatment of left main coronary artery disease: a consensus statement from the European Bifurcation Club

Mintz G, Lefèvre T, Lassen J, Testa L, Pan M, Singh J, Stankovic G, Banning A

July 20, 2018 | 10.4244/EIJ-D-18-00194

Coronary interventions

One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli A, Petronio A, Bedogni F

July 20, 2017 | 10.4244/EIJ-D-17-00246

Interventions for valvular disease

The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation

Testa L, Latib A, De Marco F, De Carlo M, Fiorina C, Barbanti M, Montone R, Agnifili M, Petronio A, Ettori F, Klugmann S, Tamburino C, Brambilla N, Colombo A, Bedogni F

December 20, 2016 | 10.4244/EIJ-D-15-00148

Interventions for valvular disease

How should I treat a mitral prosthesis rupture after left ventricular assist device implantation?

Santise G, Nardella S, Leonetti S, Buioni D, Missiroli B, Di Marzio E, Maselli D, Mylotte D, Piazza N, Modine T, De Marco F, Garatti A, Testa L, Bedogni F

July 20, 2016 | 10.4244/EIJV12I4A89

Coronary interventions

Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience

Ielasi A, Miyazaki T, Geraci S, Testa L, Abdel-Wahab M, Kawamoto H, Ruparelia N, Sato T, Caramanno G, Bedogni F, Tespili M, Colombo A, Latib A

April 8, 2016 | 10.4244/EIJV11I14A309

Coronary interventions

Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations

Naganuma T, Latib A, Costopoulos C, Oreglia J, Testa L, De Marco F, Candreva A, Chieffo A, Naim C, Montorfano M, Bedogni F, Colombo A

January 20, 2016 | 10.4244/EIJY14M11_01

CoreValve implantation for severe aortic regurgitation: a multicentre registry

Testa L, Latib A, Rossi M, De Marco F, De Carlo M, Fiorina C, Oreglia J, Petronio A, Ettori F, De Servi S, Klugmann S, Ussia G, Tamburino C, Panisi P, Brambilla N, Colombo A, Presbitero P, Bedogni F

October 20, 2014 | 10.4244/EIJV10I6A127

Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project

Barbanti M, Latib A, Sgroi C, Fiorina C, De Carlo M, Bedogni F, De Marco F, Ettori F, Petronio A, Colombo A, Testa L, Klugmann S, Poli A, Maffeo D, Maisano F, Aruta P, Gulino S, Giarratana A, Patane M, Cannata S, Imme S, Mangoni L, Rossi A, Tamburino C

May 20, 2014 | 10.4244/EIJV10I1A20

Right subclavian approach as a feasible alternative for transcatheter aortic valve implantation with the CoreValve ReValving System

Testa L, Brambilla N, Laudisa M-L, De Carlo M, Lanotte S, Latini R, Pizzocri S, Casavecchia M, Agnifili M, Giannini C, Bortolotti U, Petronio A, Bedogni F

October 26, 2012 | 10.4244/EIJV8I6A107

How should I treat a coronary "traffic jam"? A triple kissing balloon in distal left main trifurcation

Testa L, Bedogni F

March 21, 2011

Myocardial Injury following Coronary Artery Surgery versus Angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging

van Gaal W, Arnold J, Testa L, Karamitsos T, Lim C, Ponnuthurai F, Petersen S, Francis J, Selvanayagam J, Sayeed R, West N, Westaby S, Neubauer S, Banning A

January 20, 2011

Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis

Testa L, Agostoni P, Vermeersch P, Biondi-Zoccai G, van Gaal W, Bhindi R, Brilakis E, Latini R, Laudisa M-L, Pizzocri S, Lanotte S, Brambilla N, Banning A, Bedogni F

September 30, 2010

Latest news

NEW ISSUE

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

Editorial

Moving (re-shaping) the mitral annulus

Georg Nickenig

January 20, 2021

Trials Book

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Editorial

Use of intravascular OCT or IVUS to guide stent implantation.

Evelyn Regar

January 20, 2021

JAA

Last Week's JAA's: TTVr with the TriClip/MitraClip G4 System and much more...